Haleon plc (HLN.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
At close: 04:40PM BST
| Previous close | 331.50 |
| Open | 332.70 |
| Bid | 334.40 x N/A |
| Ask | 334.50 x N/A |
| Day's range | 330.80 - 336.00 |
| 52-week range | 306.80 - 353.10 |
| Volume | |
| Avg. volume | 25,791,622 |
| Market cap | 30.538B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 30.40 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.06 (1.79%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | N/A |
- Simply Wall St.
Haleon plc (LON:HLN) Shares Could Be 24% Above Their Intrinsic Value Estimate
Key Insights Using the 2 Stage Free Cash Flow to Equity, Haleon fair value estimate is UK£2.62 Haleon is estimated to...
- Zacks
Pharma Stock Roundup: AZN to Buy FUSN, PFE to Sell Stake in HLN & Other Updates
AstraZeneca (AZN) is set to acquire Fusion Therapeutics (FUSN). Pfizer (PFE) plans to sell some shares of Haleon to lower stake from 32% to 24%.
- Zacks
GSK Outperforms Industry on Strength in Key Drugs & Vaccines
Strong sales growth of GSK's specialty drugs and vaccines, the contribution from new products and positive pipeline updates should drive the stock in the future quarters.
© 2024 Yahoo. All rights reserved.